Bio-Rad Laboratories, Inc. (BIO.B) community

BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value

$379.50+0.00 (0.00%)

Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –

Community

Notes and questions about Bio-Rad Laboratories from other investors

No posts about BIO.B yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Bio-Rad Laboratories's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Mar 8, 2002
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BIO.B.

Compare: BIO.B vs RVTY · BIO.B vs BRKR · BIO.B vs WAT · BIO.B vs MTD · BIO.B vs AVTR

Revenue growth1.4% · median 4.1%

Gross margin51.9% · median 46.4%

Operating margin2.1% · median 3.1%

Net margin8.6% · median 3.6%

Company	Revenue	Growth
AVTR	$6.56B	-1.6%
WAT	$4.64B	+52.5%
MTD	$4.13B	+6.9%
BRKR	$3.50B	+1.6%
RVTY	$2.91B	+4.1%
BIO.B	$2.59B	+1.4%

Company

Exchange: NYSE
Industry: Laboratory Analytical Instruments
Fiscal year ends: December 31
Employees: 7,450
Held by institutions: 0.0%
Auditor: KPMG LLP
SEC CIK: 12208

Advertisement
300 × 250